Follow us:                    
Open/Close Menu
Society for Heart Attack Prevention and Eradication Society for Heart Attack Prevention and Eradication
1877-SHAPE11
Skip to content
  • Home
  • About SHAPE
    • Our Story
    • Mission
    • Scientific Advisory Board
    • What You Should Know
    • SHAPE Your Heart
  • Physicians
    • SHAPE Centers of Excellence
      • Program Benefits
      • Program Components
      • Testimonials
    • SHAPE Provider Certification
    • Featured Physician
    • Leaders
  • Gallery
    • SHAPE Videos Gallery
    • SHAPE Photos Gallery
    • SHAPE PowerPoints Gallery
    • SHAPE Meeting Interviews
  • News and Events
    • Golf Fore Heart
    • Other Events (Million Hearts, SHAPE-a-thon, Reds, Whites, and the Blues Benefit)
    • News
    • Webinars
    • SHAPE Symposia
  • Provider Locator

Donate or Volunteer

SHAPE Presentations

  • AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
    Date: Mon Jan 8 4:33
  • AHA SHAPE Symposium 2017 Dr. Kloner Presentation
    Date: Mon Jan 8 4:32
  • AHA SHAPE Symposium 2017 Dr. Greenland Presentation
    Date: Mon Jan 8 4:31
  • AHA SHAPE Symposium 2017 Dr. Yen Presentation
    Date: Mon Jan 8 4:30
  • AHA SHAPE Symposium 2017 Dr. Slomka Presentation
    Date: Mon Jan 8 4:27
  • Vu lplaque1 pasterkamp
    Date: Mon Sep 19 19:32
  • Vulnerable plaque vulnerable patient
    Date: Mon Sep 19 19:32
  • Vulnerable plaque overview
    Date: Mon Sep 19 19:32
  • Vulnerable patient talk in poland
    Date: Mon Sep 19 19:32
  • Vulnerable patient slides without movies
    Date: Mon Sep 19 19:32
  • Vulnerable patient slides with movies
    Date: Mon Sep 19 19:32
  • Vulnerable patient mar 04
    Date: Mon Sep 19 19:32
  • Vulnerable (thrombogenic blood
    Date: Mon Sep 19 19:32
  • Vuln shape aha 2005
    Date: Mon Sep 19 19:32
  • Vuln plaque poster burke
    Date: Mon Sep 19 19:32
  • Vp watch editorial_slide 25short-
    Date: Mon Sep 19 19:32
  • Vp watch editorial_slide25
    Date: Mon Sep 19 19:32
  • Vp watch editorial_slide25short-
    Date: Mon Sep 19 19:32
  • Vp watch2002
    Date: Mon Sep 19 19:32
  • Vp symposium31602
    Date: Mon Sep 19 19:32
  • Vpschoenhagen
    Date: Mon Sep 19 19:32
  • Vp meeting orlando2003_new template
    Date: Mon Sep 19 19:32
  • Vpiii lobby-02
    Date: Mon Sep 19 19:32
  • Vp
    Date: Mon Sep 19 19:32
  • Vp.org cimit harvard
    Date: Mon Sep 19 19:32
  • Vp texas by yuan
    Date: Mon Sep 19 19:32
  • Vp watch editorial - v2 n3- 2002
    Date: Mon Sep 19 19:32
  • Vp watch editorial - v2 n2- 2002
    Date: Mon Sep 19 19:32
  • Vp watch editorial - v2 n6- 2002
    Date: Mon Sep 19 19:32
  • Vp watch editorial - v2 n4- 2002
    Date: Mon Sep 19 19:32
  • Vp symposium 3 16-02
    Date: Mon Sep 19 19:32
  • Vp schoenhagen
    Date: Mon Sep 19 19:32
  • Vp slides
    Date: Mon Sep 19 19:32
  • Vp presentation jar 3 29 03
    Date: Mon Sep 19 19:32
  • Vp paper 7 pics (aeha logo)
    Date: Mon Sep 19 19:32
  • Vp lightlab kolstad (industry)
    Date: Mon Sep 19 19:32
  • Vp 2002 talk show copy galis
    Date: Mon Sep 19 19:32
  • Voorbeeld3 dhisto
    Date: Mon Sep 19 19:32
  • Volcano avi
    Date: Mon Sep 19 19:32
  • Visualization of atherosclerotic vulnerable plaque
    Date: Mon Sep 19 19:32
  • Vogel endothelial function cv es
    Date: Mon Sep 19 19:32
  • Virmani
    Date: Mon Sep 19 19:32
  • Vascular interventions
    Date: Mon Sep 19 19:32
  • Virella
    Date: Mon Sep 19 19:32
  • Vascular interventions atalar- johns hopkins
    Date: Mon Sep 19 19:32
  • V2n31
    Date: Mon Sep 19 19:32
  • Updated power point presentation of the vulnerable patient manuscript
    Date: Mon Sep 19 19:32
  • Toyotaka
    Date: Mon Sep 19 19:32
  • Transgenic cetp dahl salt sensitive (tg53) rat model
    Date: Mon Sep 19 19:32
  • Towards immune modulation vp
    Date: Mon Sep 19 19:32
  • Tlr4 circulation
    Date: Mon Sep 19 19:32
  • Towards immune modulation vp 16 11 gkh
    Date: Mon Sep 19 19:32
  • Tissue contrast
    Date: Mon Sep 19 19:32
  • Thermographya novel approach for the identification of vp
    Date: Mon Sep 19 19:32
  • Thermography iii
    Date: Mon Sep 19 19:32
  • Thermography early clinical correlations
    Date: Mon Sep 19 19:32
  • Thermo elastography
    Date: Mon Sep 19 19:32
  • The balancee of proteolysis
    Date: Mon Sep 19 19:32
  • Thermal hetrogeneity clinical syndrome 2
    Date: Mon Sep 19 19:32
  • The fat fed apoe ko mouse- chris jackson- u of bristol
    Date: Mon Sep 19 19:32
  • The prevalence of inflammatory cells in non ruptured atherosclerotic plaques
    Date: Mon Sep 19 19:32
  • The prev of inf cells in nonrupt a. plaque pasterkamp- part 2
    Date: Mon Sep 19 19:32
  • The new design basket catheter system
    Date: Mon Sep 19 19:32
  • The entire poster presentation of vp symposium acc 2003
    Date: Mon Sep 19 19:32
  • Tct recognition of vulnerable plaque guidelines
    Date: Mon Sep 19 19:32
  • Tct fat poster-title
    Date: Mon Sep 19 19:32
  • Tct mri 2001
    Date: Mon Sep 19 19:32
  • Tct arrow pics, landscape
    Date: Mon Sep 19 19:32
  • Taylor.aeha cac imt progression talk.1
    Date: Mon Sep 19 19:32
  • Tawakol
    Date: Mon Sep 19 19:32
  • Symposium jang
    Date: Mon Sep 19 19:16
  • Stroes
    Date: Mon Sep 19 19:16
  • Strains vp
    Date: Mon Sep 19 19:16
  • Stephanes talk aeha
    Date: Mon Sep 19 19:16
  • Stenosis vs risk
    Date: Mon Sep 19 19:16
  • Stenosis severity and risk benefit
    Date: Mon Sep 19 19:16
  • Stein cimt for shape 11-05
    Date: Mon Sep 19 19:16
  • Stefanadis
    Date: Mon Sep 19 19:16
  • Statins are associated
    Date: Mon Sep 19 19:16
  • Statin periomort
    Date: Mon Sep 19 19:16
  • Spio mri studies by dr naghavi-presented to ge-amersham
    Date: Mon Sep 19 19:16
  • Spio mri studies by dr naghavi
    Date: Mon Sep 19 19:16
  • Spio mri studies by dr naghavi - presented to ge-amersham
    Date: Mon Sep 19 19:16
  • Spio mri studies by dr naghavi - amersham oct 2003 - part 1
    Date: Mon Sep 19 19:16
  • Spio cytokinejan28
    Date: Mon Sep 19 19:16
  • Spio mri studies by dr naghavi - amersham oct 2003 - part2
    Date: Mon Sep 19 19:16
  • Spio cytokinejan28-2
    Date: Mon Sep 19 19:16
  • Spio uptake by macrophages
    Date: Mon Sep 19 19:16
  • Spio photo
    Date: Mon Sep 19 19:16
  • Spectroscopic fiber optic catheter tania - aha 2001
    Date: Mon Sep 19 19:16
  • Spatial encoding part_2
    Date: Mon Sep 19 19:16
  • Spect ct -dan berman
    Date: Mon Sep 19 19:16
  • Slides 25 28
    Date: Mon Sep 19 19:16
  • Slides 29 38
    Date: Mon Sep 19 19:16
  • Slides naqvi
    Date: Mon Sep 19 19:16
  • Slides 21 24
    Date: Mon Sep 19 19:16
  • Slides 9 20
    Date: Mon Sep 19 19:16
  • Slides 20 37 -vulnerable patient with movies
    Date: Mon Sep 19 19:16
  • Slides 1 20 -vulnerable patient with movies
    Date: Mon Sep 19 19:16
  • Slides 1 8
    Date: Mon Sep 19 19:16
  • Slides2938
    Date: Mon Sep 19 19:16
  • Slides2528
    Date: Mon Sep 19 19:16
  • Slides920
    Date: Mon Sep 19 19:16
  • Slides2124
    Date: Mon Sep 19 19:16
  • Slides18
    Date: Mon Sep 19 19:16
  • Slagerperspective
    Date: Mon Sep 19 19:16
  • Slide shows of uptake of spio by macrophages and monocytes10
    Date: Mon Sep 19 19:16
  • Slager1
    Date: Mon Sep 19 19:16
  • Silvio flu
    Date: Mon Sep 19 19:16
  • Shuzou
    Date: Mon Sep 19 19:16
  • Silvio sept 24
    Date: Mon Sep 19 19:16
  • Shoenhagen
    Date: Mon Sep 19 19:16
  • Shape a-thon clinton
    Date: Mon Sep 19 19:16
  • Shape symposium slide presentation
    Date: Mon Sep 19 19:16
  • Shape aha 2005
    Date: Mon Sep 19 19:16
  • Seferovic
    Date: Mon Sep 19 19:16
  • Shah vaccine
    Date: Mon Sep 19 19:16
  • Schwartz debate aha 2002
    Date: Mon Sep 19 19:16
  • Scd
    Date: Mon Sep 19 19:16
  • Saloner presentation
    Date: Mon Sep 19 19:16
  • Rumberger vp discussion 11 03
    Date: Mon Sep 19 19:16
  • Rumberger 2nd vp symposium 3 6 04
    Date: Mon Sep 19 19:16
  • Rumberger
    Date: Mon Sep 19 19:16
  • Rumberg 4
    Date: Mon Sep 19 19:16
  • Rumberg3
    Date: Mon Sep 19 19:16
  • Revisiting the basics culprit vs non culprit
    Date: Mon Sep 19 19:16
  • Revisiting the basics culprit vs non culprit
    Date: Mon Sep 19 19:16
  • Rumberg1
    Date: Mon Sep 19 19:16
  • Ricenano
    Date: Mon Sep 19 19:16
  • Resp infection of apoe ko mice and plaque inflammation
    Date: Mon Sep 19 19:16
  • Rumberg2
    Date: Mon Sep 19 19:16
  • Research findings
    Date: Mon Sep 19 19:16
  • Recent results and findings.
    Date: Mon Sep 19 19:16
  • Progress with the a 3 fr nir fiber optic catheter
    Date: Mon Sep 19 19:16
  • Pulse sequences gradient echo
    Date: Mon Sep 19 19:16
  • Project introduction
    Date: Mon Sep 19 19:16
  • Preset3
    Date: Mon Sep 19 19:16
  • Presentation1
    Date: Mon Sep 19 19:16
  • Ppt for adelson sketch
    Date: Mon Sep 19 19:16
  • Positive remodeling slides for ralph
    Date: Mon Sep 19 19:16
  • Positive remodeling for ralph
    Date: Mon Sep 19 19:16
  • Polymophism in the promoter
    Date: Mon Sep 19 19:16
  • Plaque petct
    Date: Mon Sep 19 19:16
  • Pharmacologic treatment of vulnerable plaque
    Date: Mon Sep 19 19:16
  • Plaque rupture definition
    Date: Mon Sep 19 19:16
  • Plaque severity and coronary occlusion
    Date: Mon Sep 19 19:16
  • Plaque inflammation july 2
    Date: Mon Sep 19 19:16
  • Percutaneous coronary intervention
    Date: Mon Sep 19 19:16
  • Plaque inflammation in atherosclerotic rabbits
    Date: Mon Sep 19 19:16
  • Patrick updown
    Date: Mon Sep 19 19:16
  • Plaque characterization with oct
    Date: Mon Sep 19 19:16
  • Phil graham new
    Date: Mon Sep 19 19:16
  • Peter libby, md
    Date: Mon Sep 19 19:16
  • Periadventitial fat
    Date: Mon Sep 19 19:16
  • Percutaneouse
    Date: Mon Sep 19 19:16
  • Pbg vp mar02_final
    Date: Mon Sep 19 19:16
  • Percutaneous coronary intervention by hossein
    Date: Mon Sep 19 19:16
  • Percutaneouse coronary intervention
    Date: Mon Sep 19 19:16
  • Pasterkamp1
    Date: Mon Sep 19 19:16
  • Pasterkamp2
    Date: Mon Sep 19 19:16
  • Pasterkamp
    Date: Mon Sep 19 19:16
  • Pandemic of cvd atlanta
    Date: Mon Sep 19 19:16
  • Out of hospital
    Date: Mon Sep 19 19:16
  • Pancoronary therapy with ipdd
    Date: Mon Sep 19 19:16
  • Out of hospital sudden cardiac death (scd) declining or escalating
    Date: Mon Sep 19 19:16
  • Out of hospital sudden cardiac death(scd)
    Date: Mon Sep 19 19:16
  • Out of hospital 2
    Date: Mon Sep 19 19:16
  • Optical coherence tomography optical biopsy with a short photonic needle
    Date: Mon Sep 19 19:16
  • Optic
    Date: Mon Sep 19 19:16
  • Optical coherence tomography jang-mgh
    Date: Mon Sep 19 19:16
  • Old vulnerable patient slides without movies
    Date: Mon Sep 19 19:16
  • Old vulnerable patient slides with movies
    Date: Mon Sep 19 19:16
  • Oct with shourt phontonic needle
    Date: Mon Sep 19 19:16
  • Noninvasive mr imaging of plaque inflammation
    Date: Sat Sep 17 22:42
  • Non invasive imaging of the vulnerable plaque and the vulnerable patient ge imatron
    Date: Sat Sep 17 22:42
  • Non invasive detection of vulnerable plaque 2
    Date: Sat Sep 17 22:42
  • Non enhancement mri of rabbit1
    Date: Sat Sep 17 22:42
  • Non invasive detection of vulnerable plaque using spio enhanced mri
    Date: Sat Sep 17 22:42
  • Nmr intro1
    Date: Sat Sep 17 22:42
  • Nitrate tolerance
    Date: Sat Sep 17 22:42
  • Nmr relaxation times
    Date: Sat Sep 17 22:42
  • Nirs
    Date: Sat Sep 17 22:42
  • Nih ppg 9-021
    Date: Sat Sep 17 22:42
  • Nir near to far slides lodder
    Date: Sat Sep 17 22:42
  • Nir spectroscopy lodder- u of kentucky
    Date: Sat Sep 17 22:42
  • Nir poster
    Date: Sat Sep 17 22:42
  • New insight to vp plaque imaging cvpr
    Date: Sat Sep 17 22:42
  • Nir catheter final
    Date: Sat Sep 17 22:42
  • Nir near to far from our expectations
    Date: Sat Sep 17 22:42
  • Nilssonetal
    Date: Sat Sep 17 22:42
  • Nilsson
    Date: Sat Sep 17 22:42
  • Navab's an oral hdl
    Date: Sat Sep 17 22:42
  • Nih ppg 9-02
    Date: Sat Sep 17 22:42
  • New insights into vulnerable plaque
    Date: Sat Sep 17 22:42
  • New thermography catheters
    Date: Sat Sep 17 22:42
  • New advances in thermography
    Date: Sat Sep 17 22:42
  • Near infrared spectroscopy 2
    Date: Sat Sep 17 22:42
  • Navab hdl
    Date: Sat Sep 17 22:42
  • Naghavi
    Date: Sat Sep 17 22:42
  • Naghavi cimit feb12-2002
    Date: Sat Sep 17 22:42
  • My talk at tct04
    Date: Sat Sep 17 22:42
  • Mri spio
    Date: Sat Sep 17 22:42
  • Mri system block diagram
    Date: Sat Sep 17 22:42
  • Mri of atherosclerotic plaque in apo e ko mice
    Date: Sat Sep 17 22:42
  • Mri applications in cardiovascular medicine
    Date: Sat Sep 17 22:42
  • Mri blush sing
    Date: Sat Sep 17 22:42
  • Mr images of human carotid arteries
    Date: Sat Sep 17 22:42
  • Morrisett
    Date: Sat Sep 17 22:42
  • Mr contrast agents for vp imaging philip graham
    Date: Sat Sep 17 22:42
  • Moreno mort meeting
    Date: Sat Sep 17 22:42
  • Moreno.nir vp.org acc02
    Date: Sat Sep 17 22:42
  • Monocyte recruitment into atherosclerotic plaques
    Date: Sat Sep 17 22:42
  • Molecular genetics
    Date: Sat Sep 17 22:42
  • Mol gen-1
    Date: Sat Sep 17 22:42
  • Micro array study for gene expression in vp
    Date: Sat Sep 17 22:42
  • Mn aha 05
    Date: Sat Sep 17 22:42
  • Mice and rabbits mri files
    Date: Sat Sep 17 22:42
  • Mi or scd in patients with very abnormal cardiac test results
    Date: Sat Sep 17 22:42
  • Maziar2
    Date: Sat Sep 17 22:42
  • Masanori aikawa powerpoint
    Date: Sat Sep 17 22:42
  • Mallat
    Date: Sat Sep 17 22:42
  • Macrophage uptake of cns1 1 d ( in vitro study)
    Date: Sat Sep 17 22:42
  • Macrophage apoptosis
    Date: Sat Sep 17 22:42
  • Macrophage induced proteolysis zorina galis- emory u
    Date: Sat Sep 17 22:42
  • Mace
    Date: Sat Sep 17 22:42
  • Lodder
    Date: Sat Sep 17 22:42
  • Litovsky1
    Date: Sat Sep 17 22:42
  • Life sight
    Date: Sat Sep 17 22:42
  • Libby
    Date: Sat Sep 17 22:42
  • Lecture vienna september 16 2005
    Date: Sat Sep 17 22:42
  • Kwong
    Date: Sat Sep 17 22:42
  • Kuiper
    Date: Sat Sep 17 22:42
  • Kritharides
    Date: Sat Sep 17 22:42
  • Krucoff infra redx_aha_2002_x2
    Date: Sat Sep 17 22:42
  • Koenig aeha2005 short
    Date: Sat Sep 17 22:42
  • Killer of human beings in the century
    Date: Sat Sep 17 22:42
  • Jay cohn md aha 04 aeha conf
    Date: Sat Sep 17 22:42
  • Introduction to nuclear magnetic resonance
    Date: Sat Sep 17 22:42
  • Introduction to mri
    Date: Sat Sep 17 22:42
  • Introducing a novel model
    Date: Sat Sep 17 22:42
  • Intravascular mri diagnostic and therapeutic potentials
    Date: Sat Sep 17 22:42
  • Intravascular elastography
    Date: Sat Sep 17 22:42
  • Intravascular micro bolometer catheter thi
    Date: Sat Sep 17 22:42
  • Intramural delivery of recombinant
    Date: Sat Sep 17 22:42
  • Interleukin 1, tissue necrosis factor-, and interferon- increase spio accumulation
    Date: Sat Sep 17 22:42
  • Influenza infection
    Date: Sat Sep 17 22:42
  • Inhibitory effect on arterial injury induced neointimal formation by adoptive b cell transfer in rag-1 ko mice nilssonetal
    Date: Sat Sep 17 22:42
  • Influenza infection exerts prominent
    Date: Sat Sep 17 22:42
  • Histopathological results of spio distribution in mice (after 24hs)
    Date: Sat Sep 17 22:42
  • Inflammation is not specific to culprit lesion
    Date: Sat Sep 17 22:42
  • In vivo mri of thrombi in advanced atherosclerosis
    Date: Sat Sep 17 22:42
  • Identifying new biomarkers
    Date: Sat Sep 17 22:42
  • Immunisatie1
    Date: Sat Sep 17 22:42
  • Imi beta-probe-vp-sound
    Date: Sat Sep 17 22:42
  • Imaging plaque inflammation crt
    Date: Sat Sep 17 22:42
  • Human carotid mri spio presentation files
    Date: Sat Sep 17 22:42
  • How the world dies today
    Date: Sat Sep 17 22:42
  • How can we identify the plaque at risk of rupture or thrombosis
    Date: Sat Sep 17 22:42
  • How the world dies 1st
    Date: Sat Sep 17 22:42
  • Histopathology and macropahge complete
    Date: Sat Sep 17 22:42
  • Histopathologic study of spio distribution in mice (method)
    Date: Sat Sep 17 22:42
  • Herrera
    Date: Sat Sep 17 22:42
  • Histopathologic study method
    Date: Sat Sep 17 22:42
  • Heart dialysis system
    Date: Sat Sep 17 22:42
  • Hartmut
    Date: Sat Sep 17 22:42
  • Hartmut hanke
    Date: Sat Sep 17 22:42
  • Harvey hecht md aeha sat
    Date: Sat Sep 17 22:42
  • Harats
    Date: Sat Sep 17 22:42
  • Goldschmidt1
    Date: Sat Sep 17 22:42
  • Gene array study of vp
    Date: Sat Sep 17 22:42
  • Genetic influence ppt11
    Date: Sat Sep 17 22:42
  • Genomic and proteomic screen
    Date: Sat Sep 17 22:42
  • Future generations
    Date: Sat Sep 17 22:42
  • Fuster aha-2005-dallas-biomarkers,
    Date: Sat Sep 17 22:42
  • Frequencies in sudden
    Date: Sat Sep 17 22:42
  • From pneumonia to influenza
    Date: Sat Sep 17 22:42
  • Forstermann
    Date: Sat Sep 17 22:42
  • For vp texas by yuan
    Date: Sat Sep 17 22:42
  • For suzy carotid mri-dr willersons book
    Date: Sat Sep 17 22:42
  • Final clickable pps for vp s ymposium aha 2001
    Date: Sat Sep 17 22:42
  • Final clickable pps for vp s ymposium @aha 2001
    Date: Sat Sep 17 22:42
  • For mark shape textbook coverpage
    Date: Sat Sep 17 22:42
  • For print vulnerable patient slides
    Date: Sat Sep 17 22:42
  • For elring 2
    Date: Sat Sep 17 22:42
  • Figuresforpaper 3
    Date: Sat Sep 17 22:42
  • Figuresforpaper robkrams
    Date: Sat Sep 17 22:42
  • Falk, final talk
    Date: Sat Sep 17 22:42
  • Fernandes
    Date: Sat Sep 17 22:42
  • Falk, shape aha 05, final
    Date: Sat Sep 17 22:42
  • Falk
    Date: Sat Sep 17 22:42
  • Existing intravascular imaging technology for plaque characterization
    Date: Sat Sep 17 22:42
  • Everybody has atherosclerosis
    Date: Sat Sep 17 22:42
  • Es v2n46
    Date: Wed Sep 14 6:36
  • E sv2n12
    Date: Wed Sep 14 6:36
  • Es v2n50
    Date: Wed Sep 14 6:36
  • Everybody has atherosclerosis
    Date: Wed Sep 14 6:36
  • Es v2n44
    Date: Wed Sep 14 6:36
  • Es v2n45
    Date: Wed Sep 14 6:36
  • Es v2n43
    Date: Wed Sep 14 6:36
  • Es v2n16
    Date: Wed Sep 14 6:36
  • Es v2n19
    Date: Wed Sep 14 6:36
  • Es v2n17
    Date: Wed Sep 14 6:36
  • Esv3n13
    Date: Wed Sep 14 6:36
  • Esv3 n14
    Date: Wed Sep 14 6:36
  • Esv3n12
    Date: Wed Sep 14 6:36
  • Esv3n11
    Date: Wed Sep 14 6:36
  • Esv3n10
    Date: Wed Sep 14 6:36
  • Esv3n7
    Date: Wed Sep 14 6:36
  • Esv3n5
    Date: Wed Sep 14 6:36
  • Esv3n6
    Date: Wed Sep 14 6:36
  • Esv3n3
    Date: Wed Sep 14 6:36
  • Esv3n4
    Date: Wed Sep 14 6:36
  • Esv2n51
    Date: Wed Sep 14 6:36
  • Esv3n2
    Date: Wed Sep 14 6:36
  • Esv3n1
    Date: Wed Sep 14 6:36
  • Esv2n49
    Date: Wed Sep 14 6:36
  • Esv2n47
    Date: Wed Sep 14 6:36
  • Esv2n48
    Date: Wed Sep 14 6:36
  • Esv2n42
    Date: Wed Sep 14 6:36
  • Esv2n37 b
    Date: Wed Sep 14 6:36
  • Esv2n39
    Date: Wed Sep 14 6:36
  • Esv2n41
    Date: Wed Sep 14 6:36
  • Esv2n40
    Date: Wed Sep 14 6:36
  • Esv2n36
    Date: Wed Sep 14 6:36
  • Esv2n35
    Date: Wed Sep 14 6:36
  • Esv2n37 a
    Date: Wed Sep 14 6:36
  • Esv2n34
    Date: Wed Sep 14 6:36
  • Esv2n33
    Date: Wed Sep 14 6:36
  • Esv2n32
    Date: Wed Sep 14 6:36
  • Esv2n30
    Date: Wed Sep 14 6:36
  • Esv2n13
    Date: Wed Sep 14 6:36
  • Esv2n29
    Date: Wed Sep 14 6:36
  • Esv2n27
    Date: Wed Sep 14 6:36
  • Esv2n26
    Date: Wed Sep 14 6:36
  • Esv2n28
    Date: Wed Sep 14 6:36
  • Esv2n25
    Date: Wed Sep 14 6:36
  • Esv2n24
    Date: Wed Sep 14 6:36
  • Esv2n23
    Date: Wed Sep 14 6:36
  • Esv2n22
    Date: Wed Sep 14 6:36
  • Esv2n14
    Date: Wed Sep 14 6:36
  • Esv2n21
    Date: Wed Sep 14 6:36
  • Esc macrophage homing
    Date: Wed Sep 14 6:36
  • Esv2n20
    Date: Wed Sep 14 6:36
  • Esv2n15
    Date: Wed Sep 14 6:36
  • Elastography
    Date: Wed Sep 14 6:36
  • Erling's slides for ralph
    Date: Wed Sep 14 6:36
  • Erling falk
    Date: Wed Sep 14 6:36
  • Endothelial function.aha.
    Date: Wed Sep 14 6:36
  • Erbel
    Date: Wed Sep 14 6:36
  • Editorial slidesv2n10
    Date: Wed Sep 14 6:36
  • Endothelial dysfunction screening tct 2003 - 2
    Date: Wed Sep 14 6:36
  • Embolic protection devices yadav- cleveland clinic
    Date: Wed Sep 14 6:36
  • Effect of testosterone on neo intimal plaque development
    Date: Wed Sep 14 6:36
  • Embolic protection devices
    Date: Wed Sep 14 6:36
  • Effect of testosterone on neo intimal plaque development
    Date: Wed Sep 14 6:36
  • Effect of statin on body temperature
    Date: Wed Sep 14 6:36
  • Editorial v2n7
    Date: Wed Sep 14 6:36
  • Ea smac homing-oral
    Date: Wed Sep 14 6:36
  • Editorial of the year
    Date: Wed Sep 14 6:36
  • Editorialslides v2n9
    Date: Wed Sep 14 6:36
  • Editorial38
    Date: Wed Sep 14 6:36
  • Ebt and coronary artery calcium
    Date: Wed Sep 14 6:36
  • Ebt rumberger- ohio state u- part 21
    Date: Wed Sep 14 6:36
  • Ebt calcium score
    Date: Wed Sep 14 6:36
  • Ebt calcium score a clue to invulnerable plaque in vulnerable patients
    Date: Wed Sep 14 6:36
  • Economics of screening for atherosclerosis final
    Date: Wed Sep 14 6:36
  • Ebt rumberger- ohio state u- part 4
    Date: Wed Sep 14 6:36
  • Ebt rumberger- ohio state u- part 3
    Date: Wed Sep 14 6:36
  • Ebt rumberger- ohio state u- part 1
    Date: Wed Sep 14 6:36
  • Ea slipidcoated final july 2
    Date: Wed Sep 14 6:36
  • Eas poster titles final
    Date: Wed Sep 14 6:36
  • Dr naghavi conclusion
    Date: Wed Sep 14 3:35
  • Dr zipes vulnerable patient mar 04
    Date: Wed Sep 14 3:35
  • Dr.yadavemboliz2
    Date: Wed Sep 14 3:35
  • Dropped ismrm2001-mri spio
    Date: Wed Sep 14 3:35
  • Drnaghavi
    Date: Wed Sep 14 3:35
  • Dr maseri aeha_neworleans_mar2004
    Date: Wed Sep 14 3:35
  • Dr naghavi acc04secondv_ppatientsymp_opening_welcome
    Date: Wed Sep 14 3:35
  • Drleakeresearch
    Date: Wed Sep 14 3:35
  • Dr.yadavemboliz2
    Date: Wed Sep 14 3:35
  • Dr.jang@aha2002
    Date: Wed Sep 14 3:35
  • Dr virmani
    Date: Wed Sep 14 3:35
  • Dr stone
    Date: Wed Sep 14 3:35
  • Dr naghavi's slides
    Date: Wed Sep 14 3:35
  • Dr falk's slides part ii
    Date: Wed Sep 14 3:35
  • Dr n's presentation at nano vivo seminar
    Date: Wed Sep 14 3:35
  • Dr koenig
    Date: Wed Sep 14 3:35
  • Dr fuster's slides part i
    Date: Wed Sep 14 3:35
  • Dr falk's slides part i
    Date: Wed Sep 14 3:35
  • Dna microarray application in vp research mehran
    Date: Wed Sep 14 3:35
  • Dog's heart
    Date: Wed Sep 14 3:35
  • Discussion topics
    Date: Wed Sep 14 3:35
  • Dna microarray mehran
    Date: Wed Sep 14 3:35
  • Dna microarray mehran- u of toronto
    Date: Wed Sep 14 3:35
  • Diffuse reflectance nir of plaque intracoronary device
    Date: Wed Sep 14 3:35
  • Diamantopoulos2002
    Date: Wed Sep 14 3:35
  • Diabetes and ccs
    Date: Wed Sep 14 3:35
  • Deteection of vulnerable atherosclerotic plaque by nis
    Date: Wed Sep 14 3:35
  • Detection of vulnerable atherosclerotic plaques by nis
    Date: Wed Sep 14 3:35
  • Detection of vulnerable plaque by nis
    Date: Wed Sep 14 3:35
  • Detection of vp with spectroscopy
    Date: Wed Sep 14 3:35
  • Definition of vulnerable plaque atlanta
    Date: Wed Sep 14 3:35
  • Detection of vp by mri after spio maziar
    Date: Wed Sep 14 3:35
  • Detection of production preliminary
    Date: Wed Sep 14 3:35
  • Detecting acute coronary syndrome
    Date: Wed Sep 14 3:35
  • Detection of production of reactive oxygen
    Date: Wed Sep 14 3:35
  • Dekorte
    Date: Wed Sep 14 3:35
  • Definitions of artereial remodeling
    Date: Wed Sep 14 3:35
  • Definition of vulnerable plaque naghavi- thi
    Date: Wed Sep 14 3:35
  • Definitions of arterial remodeling
    Date: Wed Sep 14 3:35
  • Damaged myocardium
    Date: Wed Sep 14 3:35
  • Carotid mri images
    Date: Tue Sep 13 2:39
  • Ca cvpr dec12
    Date: Tue Sep 13 2:39
  • Carotid array coil 2(1)
    Date: Tue Sep 13 2:39
  • Braunwald
    Date: Tue Sep 13 2:39
  • Carotid array coil 3(1)
    Date: Tue Sep 13 2:39
  • Barth imt
    Date: Tue Sep 13 2:39
  • Contrast enhanced mri of the vp black or white
    Date: Tue Sep 13 2:07
  • Contrast enhanced mri of vulnerable plaque black or white
    Date: Tue Sep 13 2:07
  • Cell culture study
    Date: Tue Sep 13 2:07
  • Carotid atherosclerotic lesion models for mri endpoints insull
    Date: Tue Sep 13 2:07
  • Carotid array coil 1
    Date: Tue Sep 13 2:07
  • Can you inherit a carotid plaque
    Date: Tue Sep 13 2:07
  • Capri
    Date: Tue Sep 13 2:07
  • Cardiac petct ahmed tawakol
    Date: Tue Sep 13 2:07
  • Budoff
    Date: Tue Sep 13 2:07
  • Buckymedicine
    Date: Tue Sep 13 2:07
  • Budoff shape-1105
    Date: Tue Sep 13 2:07
  • Bradford hill rules
    Date: Tue Sep 13 2:07
  • Boyd2002
    Date: Tue Sep 13 2:07
  • Blankenberg
    Date: Tue Sep 13 2:07
  • Biodistribution of spio in apo e deficient mice
    Date: Tue Sep 13 2:07
  • Biomarkers angiography2
    Date: Tue Sep 13 2:07
  • Boston sci
    Date: Tue Sep 13 2:07
  • Bio distribution of feridex in.ppt11
    Date: Tue Sep 13 2:07
  • Biodistribution of cns in apo e deficient mice
    Date: Tue Sep 13 2:07
  • Berk
    Date: Tue Sep 13 2:07
  • Basic molecular genetic studies in atherosclerosis
    Date: Tue Sep 13 2:07
  • Berman shape 05 fin
    Date: Tue Sep 13 2:07
  • Betasound
    Date: Tue Sep 13 2:07
  • Becker
    Date: Tue Sep 13 2:07
  • Autoimmune disease
    Date: Tue Sep 13 2:07
  • Badimon
    Date: Tue Sep 13 2:07
  • Atherothrombosis
    Date: Tue Sep 13 2:07
  • Badimon vp-05-jjb
    Date: Tue Sep 13 2:07
  • Atherosclerotic plaque, temperature, ph and lactate
    Date: Tue Sep 13 2:07
  • Atherosclerotic plaque
    Date: Tue Sep 13 2:07
  • Atherosclerosis, an autoimmune disease
    Date: Tue Sep 13 2:07
  • Atherosclerosis and its consequences (plaque rupture and
    Date: Tue Sep 13 2:07
  • Atherosclerosis, an autoimmune disease 2
    Date: Tue Sep 13 2:07
  • Atherosclerosis an autoimmune disease
    Date: Tue Sep 13 2:07
  • Atherosclerosis an autoimmune disease
    Date: Tue Sep 13 2:07
  • Asme05 ibis
    Date: Tue Sep 13 1:53
  • Atalar
    Date: Tue Sep 13 1:53
  • Arterial remodeling in stable versus unstable coronary syndromes
    Date: Tue Sep 13 1:53
  • Arterial remodeling in st vs unst cs
    Date: Tue Sep 13 1:53
  • Arterial remodeling in st vs. unst coronary synd schoenhagen1
    Date: Tue Sep 13 1:53
  • Arterial remodeling paul sch
    Date: Tue Sep 13 1:53
  • Armstrong
    Date: Tue Sep 13 1:53
  • Aortic ulcer intramural hematoma aortic dissection
    Date: Tue Sep 13 1:53
  • Antrin (motexafin lutetium) photoangioplasty
    Date: Tue Sep 13 1:53
  • Ah atk2
    Date: Tue Sep 13 1:53
  • Aeha multipeptide and passive
    Date: Tue Sep 13 1:53
  • Angioscopy
    Date: Tue Sep 13 1:53
  • Allison,james)
    Date: Tue Sep 13 1:53
  • Anatomy and function of the coronary arteries
    Date: Tue Sep 13 1:53
  • Airaksinen
    Date: Tue Sep 13 1:53
  • Aha periadventitial fat
    Date: Tue Sep 13 1:53
  • Aha 2009 v_plaque_characterization
    Date: Tue Sep 13 1:53
  • Aha 2004-no-6-ather.vp,vp-15'
    Date: Tue Sep 13 1:53
  • Aha 2005 crp cost effectiveness
    Date: Tue Sep 13 1:53
  • Aha 2001 presentation maziar
    Date: Tue Sep 13 1:53
  • Aha 2 mr lipid
    Date: Tue Sep 13 1:53
  • Aeha2004 crp lppla2newtemplate-koenig
    Date: Tue Sep 13 1:53
  • Aha2001
    Date: Tue Sep 13 1:53
  • Aeha -aha symposium-nov-2005-short
    Date: Tue Sep 13 1:53
  • Aeha muller 2
    Date: Tue Sep 13 1:53
  • Aeha immune mechanisms in atherosclerosis
    Date: Tue Sep 13 1:53
  • Aeha cea- shaw
    Date: Tue Sep 13 1:53
  • Aeha aha 2002 poster
    Date: Tue Sep 13 1:53
  • Aeha2004 crp lppla2newtemplate
    Date: Tue Sep 13 1:53
  • Adventitial fat presentation
    Date: Tue Sep 13 1:53
  • Adeli 25 28
    Date: Tue Sep 13 1:53
  • Adventitial fat macrophage density a potential new marker of vulnerability
    Date: Tue Sep 13 1:53
  • Acidic p h and atherosclerosis
    Date: Tue Sep 13 1:53
  • Adeli 29 38
    Date: Tue Sep 13 1:53
  • Accmacrophagesword
    Date: Tue Sep 13 1:53
  • Adeli 21 24
    Date: Tue Sep 13 1:53
  • Adeli 9 20
    Date: Tue Sep 13 1:53
  • Adeli 1 8
    Date: Tue Sep 13 1:53
  • Acute coronary syndrome
    Date: Tue Sep 13 1:53
  • Achenbach
    Date: Tue Sep 13 1:53
  • Accv porg
    Date: Tue Sep 13 1:53
  • Ac cculprit
    Date: Tue Sep 13 1:53
  • Acc vp-org 3-02 stone
    Date: Tue Sep 13 1:53
  • Acc v porg
    Date: Tue Sep 13 1:53
  • Acc v porg becker
    Date: Tue Sep 13 1:53
  • Acc 2005-1, v pl-vp
    Date: Tue Sep 13 1:53
  • Acc presentation macrophage (1)
    Date: Tue Sep 13 1:53
  • Acc presentation lipid coated(2)
    Date: Tue Sep 13 1:53

SHAPE Presentations 2

  • Barth imt
    Date: Wed Oct 5 21:20
  • Braunwald
    Date: Wed Oct 5 21:20
  • Acc vp-org 3-02 stone
    Date: Tue Oct 4 14:50
  • 101205 shape aha 2005 f
    Date: Tue Oct 4 14:50
  • Acc v porg becker
    Date: Tue Oct 4 14:50
  • Acc 2005-1, v pl-vp
    Date: Tue Oct 4 14:50
  • Acc presentation macrophage (1)
    Date: Tue Oct 4 14:50
  • Acc v porg
    Date: Tue Oct 4 14:50
  • Acc presentation (1)
    Date: Tue Oct 4 14:50
  • Ac cculprit
    Date: Tue Oct 4 14:50
  • Acc presentation lipid coated(2)
    Date: Tue Oct 4 14:50
  • Acc 2002 microarray mehran for print
    Date: Tue Oct 4 14:50
  • Acc booth inventory
    Date: Tue Oct 4 14:50
  • Acc 04 vuln pt
    Date: Tue Oct 4 14:50
  • Acc 2002 mehran for print
    Date: Tue Oct 4 14:50
  • Acc2002 thermography
    Date: Tue Oct 4 14:50
  • A20 gene
    Date: Tue Oct 4 14:50
  • #1 killer of human beings in the 21st century
    Date: Tue Oct 4 14:50
  • A20 is an atherosclerosis
    Date: Tue Oct 4 14:50
  • 103100
    Date: Tue Oct 4 14:50
  • 259 crp as a risk factor
    Date: Tue Oct 4 14:50
  • 511 first steps towards understanding
    Date: Tue Oct 4 14:50
  • 1688 azadpour 3 12 02
    Date: Tue Oct 4 14:50
  • 1031 talk2
    Date: Tue Oct 4 14:50
  • 510 does lxr links lipid metabolism to inflammation, or ppar
    Date: Tue Oct 4 14:50
  • 512 low t3 syndrome
    Date: Tue Oct 4 14:50
  • 509 chromosome 6p linked to high hdl
    Date: Tue Oct 4 14:50
  • 508 search for genomic and proteomic risk factors and protective factors associated with coronary heart disease
    Date: Tue Oct 4 14:50
  • 507 stenosis severity and risk benefit
    Date: Tue Oct 4 14:50
  • 506 what is the link between infection and cardiovascular events
    Date: Tue Oct 4 14:50
  • 505 definitions of arterial remodeling in post mortem and intravascular ultrasound research pasterkamp2
    Date: Tue Oct 4 14:50
  • 504 percutaneouse coronary intervention
    Date: Tue Oct 4 14:50
  • 503 troponin t and quantitative st segment depression
    Date: Tue Oct 4 14:50
  • 502 nmr relaxation times
    Date: Tue Oct 4 14:50
  • 260 mri system block diagram
    Date: Tue Oct 4 14:50
  • 253 endothelial dysfunction
    Date: Tue Oct 4 14:50
  • 501 autoimmune disease
    Date: Tue Oct 4 14:50
  • 258 dr renu virmani
    Date: Tue Oct 4 14:50
  • 261 molecular genetics and micro arrays
    Date: Tue Oct 4 14:50
  • 248 carotid atherosclerotic lesion models
    Date: Tue Oct 4 14:50
  • 257 inhibition of atherosclerosis in mice
    Date: Tue Oct 4 14:50
  • 256 spatial encoding part 2
    Date: Tue Oct 4 14:50
  • 254 nanotechnology
    Date: Tue Oct 4 14:50
  • 255 in vivo coronary sinus thermography
    Date: Tue Oct 4 14:50
  • 252 statin therapy influence on coronary calcification
    Date: Tue Oct 4 14:50
  • 250 patients with very abnormal test results
    Date: Tue Oct 4 14:50
  • 249 the most cost effective therapy
    Date: Tue Oct 4 14:50
  • 251 computed tomographic coronary artery calcium
    Date: Tue Oct 4 14:50
  • 242 lipid lowering
    Date: Tue Oct 4 14:50
  • 245 mri scanner
    Date: Tue Oct 4 14:50
  • 246 recombinant apolipoprotein ai milano
    Date: Tue Oct 4 14:50
  • 239 coronary artery calcium
    Date: Tue Oct 4 14:50
  • 247 ebct vs conventional risk factors
    Date: Tue Oct 4 14:50
  • 243 b cell
    Date: Tue Oct 4 14:50
  • 244 importance of vascular remodelling
    Date: Tue Oct 4 14:50
  • 237 vulnerable plaque in esc 2002
    Date: Tue Oct 4 14:50
  • 238 carotid array coil
    Date: Tue Oct 4 14:50
  • 241 genetic influence on carotid atherosclerosis
    Date: Tue Oct 4 14:50
  • 240 spatial encoding
    Date: Tue Oct 4 14:50
  • 235 does cd40 link atherosclerosis to thrombosis
    Date: Tue Oct 4 14:50
  • 233 cd40
    Date: Tue Oct 4 14:50
  • 234 aha 2002 guideline, 1997 or 2002
    Date: Tue Oct 4 14:50
  • 236 complement inhibitor
    Date: Tue Oct 4 14:50
  • 224 k ras polymorphism in cancer, for atherosclerosis
    Date: Tue Oct 4 14:50
  • 232 ptx3 or crp
    Date: Tue Oct 4 14:50
  • 229 propagermanium
    Date: Tue Oct 4 14:50
  • 231 genetic marker(s) of mi
    Date: Tue Oct 4 14:50
  • 230 plaque crp or myocardial crp
    Date: Tue Oct 4 14:50
  • 227 which serum should be used
    Date: Tue Oct 4 14:50
  • 228 crp, is it a risk factor not a risk marker
    Date: Tue Oct 4 14:50
  • 225 animal models of heart attack part 2
    Date: Tue Oct 4 14:50
  • 226 statins are overrated
    Date: Tue Oct 4 14:50
  • 214 how can calcium score improve your practice
    Date: Tue Oct 4 14:50
  • 222 animal models of heart attack
    Date: Tue Oct 4 14:50
  • 220 statin therapy and coronary calcification
    Date: Tue Oct 4 14:50
  • 221 images of 3 mice
    Date: Tue Oct 4 14:50
  • 223 edta chelating therapy
    Date: Tue Oct 4 14:50
  • 218 pharmacologic stabilization of vulnerable plaque
    Date: Tue Oct 4 14:50
  • 219 coronary autoregulation in vivo
    Date: Tue Oct 4 14:50
  • 216 elastography using ivus
    Date: Tue Oct 4 14:50
  • 215 antibio
    Date: Tue Oct 4 14:50
  • 213 oral apo ai mimetic peptide for reduction of atherosclerosis
    Date: Tue Oct 4 14:50
  • 217 c reactive protein
    Date: Tue Oct 4 14:50
  • 212 basic molecular genetic studies in atherosclerosis
    Date: Tue Oct 4 14:50
  • 211 statin therapy
    Date: Tue Oct 4 14:50
  • 209 trans blood vision™
    Date: Tue Oct 4 14:50
  • 208 peter libby
    Date: Tue Oct 4 14:50
  • 210 atherosclerosis, is it an autoimmune disease
    Date: Tue Oct 4 14:50
  • 204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
    Date: Tue Oct 4 14:50
  • 207 progress with the calibration of a 3 fr near infrared catheter
    Date: Tue Oct 4 14:50
  • 202 vp watch of the year 2002
    Date: Tue Oct 4 14:50
  • 205 macrophage apoptosis
    Date: Tue Oct 4 14:50
  • 206 crp lowering or crp guided trial
    Date: Tue Oct 4 14:50
  • 203 pathologic substrate of coronary plaque erosion
    Date: Tue Oct 4 14:50
  • 201 metabolic dyslipidemia
    Date: Tue Oct 4 14:50
  • 200 is coated stent the answer
    Date: Tue Oct 4 14:50
  • 199 plaque severity and coronary occlusion
    Date: Tue Oct 4 14:50
  • 198 pulse sequences
    Date: Tue Oct 4 14:50
  • 197 reducing atherosclerosis in mice
    Date: Tue Oct 4 14:50
  • 196 new thermography catheters
    Date: Tue Oct 4 14:50
  • 191 spio and t2 effect
    Date: Tue Oct 4 14:50
  • 195 hepatic synthesis and secretion of vldl
    Date: Tue Oct 4 14:50
  • 194 anatomy and function of the coronary arteries
    Date: Tue Oct 4 14:50
  • 193 apo b48 secretion and regulation
    Date: Tue Oct 4 14:50
  • 192 pericardioscopy and pericardial biopsy
    Date: Tue Oct 4 14:50
  • 184 toll like receptor 4 and atherosclerosis
    Date: Tue Oct 4 14:50
  • 190 virus infected monocyes
    Date: Tue Oct 4 14:50
  • 189 hsp 65
    Date: Tue Oct 4 14:50
  • 187 athero reversa mice
    Date: Tue Oct 4 14:50
  • 174 multicontrast mri
    Date: Tue Oct 4 14:50
  • 186 4th vulnerable plaque symposium
    Date: Tue Oct 4 14:50
  • 165 pressure wire
    Date: Tue Oct 4 14:50
  • 185 towards the future cath lab
    Date: Tue Oct 4 14:50
  • 170 insulin signaling & vldl overproduction
    Date: Tue Oct 4 14:50
  • 183 postulated mechanisms of insulin resistance
    Date: Tue Oct 4 14:50
  • 182 non invasive coronary angiography
    Date: Tue Oct 4 14:50
  • 181 cholesterol independent therapeutic effects of hdl
    Date: Tue Oct 4 14:50
  • 180 aortic thermography catheter
    Date: Tue Oct 4 14:50
  • 178 vaccination against atherosclerosis
    Date: Tue Oct 4 14:50
  • 179 chlamydophila pneumoniae
    Date: Tue Oct 4 14:50
  • 169 coronary artery surgery study
    Date: Tue Oct 4 14:50
  • 177 link between coronary and carotid
    Date: Tue Oct 4 14:50
  • 175 tissue contrast
    Date: Tue Oct 4 14:50
  • 176 coronary pan artritis
    Date: Tue Oct 4 14:50
  • 172 nir spectroscopy
    Date: Tue Oct 4 14:50
  • 173 mri guided angioplasty
    Date: Tue Oct 4 14:50
  • 151 performance of a localized fiber optic
    Date: Tue Oct 4 14:50
  • 171 mm ps the dirty dozen
    Date: Tue Oct 4 14:50
  • 168 catheter based detection of vulnerable plaque
    Date: Tue Oct 4 14:50
  • 163 infra redx
    Date: Tue Oct 4 14:50
  • 167 plaque p h heterogeneity in physiological media
    Date: Tue Oct 4 14:50
  • 166 ascorbic acid and wound healing
    Date: Tue Oct 4 14:50
  • 164 calcium in atherosclerosis
    Date: Tue Oct 4 14:50
  • 162 calcium imaging
    Date: Tue Oct 4 14:50
  • 161 oct catheter
    Date: Tue Oct 4 14:50
  • 155 dna microarray
    Date: Tue Oct 4 14:50
  • 160 5th vulnerable plaque symposium
    Date: Tue Oct 4 14:50
  • 158 genomic and proteomic risk factors
    Date: Tue Oct 4 14:50
  • 159 spio uptake by macrophages
    Date: Tue Oct 4 14:50
  • 157 distribution of coronary stenoses
    Date: Tue Oct 4 14:50
  • 156 intravascular elastography
    Date: Tue Oct 4 14:50
  • 153 mr imaging of atherosclerosis
    Date: Tue Oct 4 14:50
  • 154 plaque rupture definition
    Date: Tue Oct 4 14:50
  • 152 spio photographs
    Date: Tue Oct 4 14:50
  • 150 sudden pathology of sudden cardiac death
    Date: Tue Oct 4 14:50
  • 149 revisiting the basics
    Date: Tue Oct 4 14:50
  • 146 animal models of vulnerable plaque
    Date: Tue Oct 4 14:50
  • 148 the erythrocyte
    Date: Tue Oct 4 14:50
  • 147 vulnerable thrombogenic blood
    Date: Tue Oct 4 14:50
  • 143 plaque inflammation spio
    Date: Tue Oct 4 14:50
  • 145 intravascular elastography
    Date: Tue Oct 4 14:50
  • 144 physics of mri
    Date: Tue Oct 4 14:50
  • 142 arterial remodelling in coronary syndromes
    Date: Tue Oct 4 14:50
  • 140 mr imaging of fibrin
    Date: Tue Oct 4 14:50
  • 141 physics of mri
    Date: Tue Oct 4 14:50
  • 139 ebt calcium score
    Date: Tue Oct 4 14:50
  • 138 new vp website
    Date: Tue Oct 4 14:50
  • 137 inflammatory cells in non ruptured atherosclerotic plaques
    Date: Tue Oct 4 14:50
  • 136 framingham model and coronary events
    Date: Tue Oct 4 14:50
  • 131 the evolution of coronary atherosclerosis
    Date: Tue Oct 4 14:50
  • 135 contrast enhanced mri of vulnerable plaque
    Date: Tue Oct 4 14:50
  • 132 gene expression in atherosclerotic plaques
    Date: Tue Oct 4 14:50
  • 134 mr contrast agents for vulnerable plaque imaging
    Date: Tue Oct 4 14:50
  • 133 testosterone and neo intimal plaque development
    Date: Tue Oct 4 14:50
  • 129 inflammation and culprit lesions
    Date: Tue Oct 4 14:50
  • 130 mri assessment of human atherosclerotic disease
    Date: Tue Oct 4 14:50
  • 125 ct based characterization
    Date: Tue Oct 4 14:50
  • 128 apo e deficient mice
    Date: Tue Oct 4 14:50
  • 126 micro array study for gene expression
    Date: Tue Oct 4 14:50
  • 124 nitrate tolerance
    Date: Tue Oct 4 14:50
  • 127 arterial wall injury and temperature
    Date: Tue Oct 4 14:50
  • 113 intravascular characterization of atheroscleotic lesions
    Date: Tue Oct 4 14:50
  • 123 coronary dialsysis
    Date: Tue Oct 4 14:50
  • 120 mr imaging for the evaluation of carotid atherosclerosis
    Date: Tue Oct 4 14:50
  • 122 drug eluting stents
    Date: Tue Oct 4 14:50
  • 121 non invasive imaging of coronary arteries
    Date: Tue Oct 4 14:50
  • 118 cell culture study
    Date: Tue Oct 4 14:50
  • 119 carotid array coil
    Date: Tue Oct 4 14:50
  • 112 macrophage uptake of cns1 1 d
    Date: Tue Oct 4 14:50
  • 114 evaluation of atherosclerotic plaque
    Date: Tue Oct 4 14:50
  • 117 mr images of human carotid arteries
    Date: Tue Oct 4 14:50
  • 116 stabilization of vulnerable plaques
    Date: Tue Oct 4 14:50
  • 115 genomic and proteomic screen
    Date: Tue Oct 4 14:50
  • 109 anatomy of the atherosclerotic plaque
    Date: Sun Oct 2 23:46
  • 110 electron beam tomography
    Date: Sun Oct 2 23:46
  • 108 cetp expression
    Date: Sun Oct 2 23:46
  • 104 new advances in thermography
    Date: Sun Oct 2 23:46
  • 105 nir spectroscopy studies
    Date: Sun Oct 2 23:46
  • 107 spio in apo e mouse
    Date: Sun Oct 2 23:46
  • 106 detection of crp
    Date: Sun Oct 2 23:46
  • 103 in vivo mri of thrombi
    Date: Sun Oct 2 23:46
  • 082 smoking and plaque inflammation
    Date: Sun Oct 2 23:46
  • 100 non enhancement mri of rabbit
    Date: Sun Oct 2 23:46
  • 102 hot plaque
    Date: Sun Oct 2 23:46
  • 101 adventitial fat macrophage density
    Date: Sun Oct 2 23:46
  • 099 inhibitory effect on arterial injury
    Date: Sun Oct 2 23:46
  • 098 red wine and heart disease
    Date: Sun Oct 2 23:46
  • 097 atherosclerotic lesions have regions of low p h
    Date: Sun Oct 2 23:46
  • 094 spectroscopic fiber optic catheter
    Date: Sun Oct 2 23:46
  • 095 thermography idenitfying vulnerable plaques
    Date: Sun Oct 2 23:46
  • 091 vascular dysfunction in hypercholesterolemic rabbits
    Date: Sun Oct 2 23:46
  • 093 multi slice fast ct
    Date: Sun Oct 2 23:46
  • 096 mri imaging of atherosclerosis using spio
    Date: Sun Oct 2 23:46
  • 092 il18 and il18 bp in atherosclerosis
    Date: Sun Oct 2 23:46
  • 089 intravascular magnetic resonance imaging
    Date: Sun Oct 2 23:46
  • 090 carotid atherosclerotic lesion model
    Date: Sun Oct 2 23:46
  • 088 optical coherence tomography
    Date: Sun Oct 2 23:46
  • 087 mri of atherosclerotic plaque in apo e ko mice
    Date: Sun Oct 2 23:46
  • 078 infrared spectroscopy of atherosclerotic plaque
    Date: Sun Oct 2 23:46
  • 083 non invasive imaging of the vulnerable plaque
    Date: Sun Oct 2 23:46
  • 086 unstable angina, lad stenosis
    Date: Sun Oct 2 23:46
  • 085 introduction to nuclear magnetic resonance
    Date: Sun Oct 2 23:46
  • 084 biodistribution of spio in apo e mouse
    Date: Sun Oct 2 23:46
  • 081 carotid artery plaque
    Date: Sun Oct 2 23:46
  • 080 intravascular micro bolometer catheter
    Date: Sun Oct 2 23:46
  • 077 intravascular ultrasound for plaque characterization
    Date: Sun Oct 2 23:46
  • 079 monocyte recruitment into atherosclerotic plaques
    Date: Sun Oct 2 23:46
  • 076 cardiac magnetic resonance imaging
    Date: Sun Oct 2 23:46
  • 074 influenza infection effects
    Date: Sun Oct 2 23:46
  • 075 immune modulation
    Date: Sun Oct 2 23:46
  • 073 collagenases vs collagen
    Date: Sun Oct 2 23:46
  • 072 ct angiography
    Date: Sun Oct 2 23:46
  • 071 carotid array coil
    Date: Sun Oct 2 23:46
  • 070 visualization of atherosclerotic vulnerable plaque
    Date: Sun Oct 2 23:46
  • 059 can oct catheter see plaque macrophages
    Date: Sun Oct 2 23:46
  • 068 from vulnerable plaque to vulnerable patient
    Date: Sun Oct 2 23:46
  • 069 thermography
    Date: Sun Oct 2 23:46
  • 067 the holy grail of cardiology
    Date: Sun Oct 2 23:46
  • 066 protein structure as a target for ligand design
    Date: Sun Oct 2 23:46
  • 065 association for eradication of heart attack
    Date: Sun Oct 2 23:46
  • 064 vulnerable thrombogenic blood
    Date: Sun Oct 2 23:46
  • 063 plaque characterization with oct
    Date: Sun Oct 2 23:46
  • 062 pathologic study of the effect of spio injection
    Date: Sun Oct 2 23:46
  • 058 optical coherence tomography
    Date: Sun Oct 2 23:46
  • 061 a nano mega initiative
    Date: Sun Oct 2 23:46
  • 060 coronary atherosclerosis with multislice ct
    Date: Sun Oct 2 23:46
  • 057 coronary endothelial shear stress profiling
    Date: Sun Oct 2 23:46
  • 056 extra mri images
    Date: Sun Oct 2 23:46
  • 055 mri applications in cardiovascular medicine
    Date: Sun Oct 2 23:46
  • 054 vulnerable plaques and vulnerable patients
    Date: Sun Oct 2 23:46
  • 053 histologic evidence of spio accumulation in vulnerable plaques
    Date: Sun Oct 2 23:46
  • 049 macrophage induced proteolysis
    Date: Sun Oct 2 23:46
  • 052 non invasive high resolution detection
    Date: Sun Oct 2 23:46
  • 051 plaque inflam detection in atherosclerotic rabbits
    Date: Sun Oct 2 23:46
  • 050 periadventitial fat
    Date: Sun Oct 2 23:46
  • 048 adventitial fat presentation
    Date: Sun Oct 2 23:46
  • 047 bio distribution of feridex in
    Date: Sun Oct 2 23:46
  • 046 respiratory infection of apoe ko mice and plaque inflammation
    Date: Sun Oct 2 23:46
  • 043 thermo elastography
    Date: Sun Oct 2 23:46
  • 045 how can we identify the plaque at risk of rupture or thrombosis
    Date: Sun Oct 2 23:46
  • 042 introducing a novel model
    Date: Sun Oct 2 23:46
  • 044 mice mri
    Date: Sun Oct 2 23:46
  • 041 transgenic cetp dahl salt sensitive (tg53) rat model
    Date: Sun Oct 2 23:46
  • 040 center for vulnerable plaque research
    Date: Sun Oct 2 23:46
  • 036 dogs heart
    Date: Sun Oct 2 23:46
  • 038 tct arrow pics, landscape
    Date: Sun Oct 2 23:46
  • 039 mr contrast agents for vulnerable plaque imaging
    Date: Sun Oct 2 23:46
  • 037 association for eradication of heart attack
    Date: Sun Oct 2 23:46
  • 035 respiratory infection of apo e ko mice
    Date: Sun Oct 2 23:46
  • 034 everybody has atherosclerosis
    Date: Sun Oct 2 23:46
  • 033 uptakes of spio by murine
    Date: Sun Oct 2 23:46
  • 7
    Date: Sun Oct 2 23:46
  • 032 hossein eftekhari,md
    Date: Sun Oct 2 23:46
  • 031
    Date: Sun Oct 2 23:46
  • 8
    Date: Sun Oct 2 23:46
  • 5
    Date: Sun Oct 2 23:46
  • 4th vulnerable plaque symposium
    Date: Sun Oct 2 23:46
  • 3rd vulnerable plaque rumberger 3 16-02 4
    Date: Sun Oct 2 23:46
  • 4
    Date: Sun Oct 2 23:46
  • 3rd vulnerable plaque rumberger 3 16-02 4
    Date: Sun Oct 2 23:46
  • 3rd vulnerable plaque rumberger 3 16-02 1
    Date: Sun Oct 2 23:46
  • 3rd vulnerable plaque rumberger 3 16-02 3
    Date: Sun Oct 2 23:46
  • 3rd vulnerable plaque rumberger 3 16-02 3
    Date: Sun Oct 2 23:46
  • 3rd vulnerable plaque rumberger 3 16-02 1
    Date: Sun Oct 2 23:46
  • 1
    Date: Sun Oct 2 23:46
  • 3rd vulnerable plaque rumberg 3 16-02 2
    Date: Sun Oct 2 23:46
  • 3rd vulnerable plaque rumberg 3 16-02 2
    Date: Sun Oct 2 23:46
  • 3rd vp symposium jang
    Date: Sun Oct 2 23:46
  • 3rd vp symposium jang
    Date: Sun Oct 2 23:46
  • 3 mouse
    Date: Sun Oct 2 23:46
  • 3rd vp symposium herrera
    Date: Sun Oct 2 23:46
  • 1 spio-mri studies by dr naghavi - amersham oct 2003
    Date: Sun Oct 2 23:46
  • 2
    Date: Sun Oct 2 23:46
  • Single Session of MR Coronary Angiography and Myocardial Perfusion Imaging
    Date: Fri May 9 14:25
  • Medication non-adherence is associated with a broad range of adverse outcomes in patients with coronary artery disease
    Date: Fri May 9 14:25
  • Turbulent blood flow plays an essential localizing role in the development of atherosclerotic lesions in experimentally-induced hypercholesterolemia in rats
    Date: Fri May 9 14:25
  • Predictors of persistence with antihypertensive therapy: results from the NHANES
    Date: Fri May 9 14:25
  • Phosphorus levels are associated with subclinical atherosclerosis in the general population
    Date: Fri May 9 14:24
  • Cigarette smoking, systolic blood pressure, and cardiovascular diseases in the asia-pacific region
    Date: Fri May 9 14:24
  • The Impact of carotid plaque screening on motivation for smoking cessation and knowledge retention about atherosclerosis
    Date: Fri May 9 14:24
  • Coronary artery disease among asymptomatic diabetic and non-diabetic patients undergoing coronary CT angiography
    Date: Fri May 9 14:04
  • No correlation and low agreement of imaging and inflammatory atherosclerosis’ markers in familial hypercholesterolemia
    Date: Fri May 9 14:04
  • Incremental predictive value of vascular assessments combined with the Framingham Risk Score for prediction of coronary events in subjects of low intermediate risk
    Date: Fri May 9 14:04
  • Nonalcoholic fatty liver disease and carotid atherosclerosis in children
    Date: Fri May 9 14:04

.

CONTACT SHAPE

Society for Heart Attack
Prevention and Eradication
Palo Alto Square
3000 El Camino Real, Suite 200
Palo Alto, CA 94306
Tel:-877-SHAPE11 (1-877-742-7311)
Email: info@shapesociety.org

THE SHAPE BOOK

BookCoverThumb

Follow us

Facebooktwittergoogle_pluslinkedinyoutube
          SHAPE supports
   No More Broken Hearts
ShapeSociety, Copyright 2020
Top ↑
Follow us:                        